Real-world treatment and quality of life (QOL) in locally advanced or metastatic urothelial carcinoma (la/mUC) in Saudi Arabia, Singapore, South Korea, Taiwan, and Turkey. This is an ASCO Meeting ...
Evaluating Minority Participation in Radiation Oncology Clinical Trials and the Impact of COVID-19 on Enrollment in a Large Integrated Academic Satellite Network This is a retrospective ...
Covalent Bruton tyrosine kinase inhibitors (BTKis) have improved CLL management, but discontinuation due to adverse events and disease progression remains a challenge. Sequential BCL2 inhibitor ...
A study of patients undergoing radical cystectomy for MIBC found that 88.3% did not receive adjuvant therapy and 43.3% did not receive neoadjuvant therapy. Amid a rapidly evolving landscape in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results